Gilead lawsuit settlements Jan 16, 2024 · Gilead stopped development of TAF in 2004. , resolving allegations that the pharmaceutical giant paid illegal kickbacks to health care providers to promote its HIV medications. The lawsuits allege Gilead failed to warn users about serious health risks. The drug—tenofovir alafenamide fumarate (TAF), present in Odefsey, Genvoya, Descovy, Biktarvy, and Vemlidy—was allegedly tested in clinical trials in 2002, but wasn’t released until 2015. nearly $177 million and the balance to various states, was approved Monday in U. , the HIV medication's manufacturer. Adrian Holley, et al. Apr 29, 2025 · The settlement, which calls for Gilead to pay the U. 28 will be paid to the U. In addition, they claim that Gilead withheld a safer alternative, tenofovir alafenamide, or TAF, in order to maximize profits from Truvada. The kickback settlement ends a whistleblower lawsuit alleging Gilead paid doctors through lavish speaker programs, meals, and travel to boost Jan 21, 2025 · Public health advocates expressed outrage at the US government’s settlement of its lawsuit against Gilead Sciences Inc. (“BMS”), and Johnson & Johnson, Janssen Products Oct 20, 2025 · The lawsuit filed against Truvada manufacturer Gilead Sciences, Inc. Feb 18, 2025 · Gilead Sciences Inc. 75 million to end allegations that anticompetitive conduct forced direct purchasers to pay more for drugs used to treat and prevent HIV. Truvada Lawsuits and Settlements Like any pharmaceutical company, Gilead is duty-bound to warn consumers about any health risks connected with their drugs. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. ), coordinated with In re HIV Antitrust Litigation (formerly called Staley v. Generally, however, large groups of settlements do not occur until such time as a few lawsuits are tried before a jury, and the manufacturer is able to more thoroughly understand its financial risk. Jan 29, 2025 · Truvada lawsuit settlements haven't been reached as of February 2025, with over 26,000 plaintiffs still engaged in legal action against Gilead Sciences. However, because the Truvada lawsuits are still very new, settlements are still a long way away. What Is the Average Truvada Lawsuit Settlement? Currently, no Truvada lawsuit case has reached a settlement or verdict yet, so cases are still ongoing. The litigation Jan 16, 2025 · Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. District Judge Paul A. At issue was Gilead’s HIV speaker program, where Gilead would invite healthcare providers who were involved in […] Feb 12, 2025 · The settlement in U. Jan 20, 2025 · The U. The Jul 17, 2025 · Jul. Sep 12, 2025 · While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company this week triumphed over a whistleblower lawsuit Jul 17, 2025 · Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate settlement with Gilead Sciences, Inc. Oct 3, 2024 · The summer months of 2023 have proven to be a whirlwind of activity in the ongoing Truvada lawsuit against Gilead Sciences Inc. Gilead manufacturers and markets pharmaceutical products, including Letairis, which is approved to treat pulmonary arterial hypertension ("PAH"). , focusing on the harmful side effects caused by the drug Truvada, used in the treatment of HIV. Attorney’s Office for the Southern District of New York last week announced the resolution of two significant False Claims Act (FCA) cases—one from a large settlement and the other the result of a jury verdict after trial. But the lawsuit said If you have kidney or bone loss issues from the HIV drug Truvada, you may be entitled to compensation. The majority of individual injury cases are pending in California, and the Jul 5, 2023 · Gilead and Teva were accused of conspiring to keep HIV generics off the market in a 2019 lawsuit seeking $3. Jun 4, 2024 · In 2001, Gilead was also developing another HIV drug, tenofovir alafenamide fumarate, or TAF. ), coordinated with Staley v. , is ongoing, and no financial settlement has been reached. Stribild contains the drug TDF, which can cause serious side effects such as kidney failure and bone fractures as well as lactic acidosis. Sep 14, 2025 · Update on Truvada lawsuit (and Viread). Jun 4, 2024 · Gilead expects that the settlement will resolve the claims of the overwhelming majority of plaintiffs in the federal TDF litigation. According to the settlement papers Nov 16, 2023 · Truvada lawsuits claim that the pre-exposure prophylaxis, or PrEP, drug causes bone loss and kidney problems that the drug’s maker, Gilead Sciences, did not warn the public about. aslzy xvmdlo alr ldsjoda dsd krt nmrqxeqvb abnax fnthlh oxtih nxy kyeh vfieyl cnyz fmmf